HIV Gene Therapy

Congenital HIV Offers Unique Opportunity for Gene Therapy Rescue

Published in Gene Therapy Weekly, December 18th, 1995

Researchers suggested recently that congenital HIV infection may be uniquely suited to a genetic engineering based therapy.

The birth of any child provides the once in a lifetime opportunity to collect autologous cord blood. If the child is born to an HIV infected mother, and is a victim of congenital transmission of this disease, a unique opportunity presents itself to treat the child with a protocol being developed by researchers.

B.R. Davis et al. presented encouraging data at the 37th Annual Meeting of the American Society of Hematology, held December 1-5, 1995, (abstract titled "Genetic Modification of Stem/Progenitor Cells to Protect...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1995-12-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry